Tiny particles light up tumors in new imaging study
NCT ID NCT01266096
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new radioactive dye attached to tiny silica particles to improve PET scans for people with melanoma or malignant brain tumors. Ten participants will receive a single injection of the tracer to see how it spreads in the body and how much radiation it gives off. The goal is to gather information for future imaging or treatment studies, not to treat the cancer itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 124I-cRGDY-PEG-dots (a radioactive dye attached to silica nanoparticles)
- What this could lead to
- If successful, this could lead to more accurate PET scans for detecting melanoma and brain tumors, helping doctors see cancer more clearly.
- What could go wrong
- This is a very early, small study with only 10 participants. It is not designed to treat cancer, and the findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT BRAIN TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.